Scientific deep-dive

Why GLP-1 Drugs Make You Tired — and What Nobody Has Studied

Fatigue runs 11% against 5% on placebo, and rises with dose: 5% to 9% to 11%. That dose-response is the strongest sign the drug is causing it — and almost nothing else has been studied.

By Nora Bissett · Pricing Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
6 min read·1 citations

Fatigue is in the label, it is roughly twice as common as on placebo, and it gets more common as the dose goes up: 5% on placebo, 9% at 2.4 mg, 11% at 7.2 mg.[1] That dose-response is the most useful thing anyone can tell you about it, because it is the strongest available sign that the drug is causing this rather than the weight loss. Beyond that the honest answer is that almost nobody has studied it, and what follows is reasoning rather than evidence.

What the label counted

In the main adult weight-management trials, covering 2,116 people on semaglutide 2.4 mg, fatigue was reported by 11% against 5% on placebo.[1] It sits in the adverse reactions table alongside nausea and headache — the common, generally self-limiting group — not in any warning section.

A separate table covering the 7.2 mg dose reports the three-way comparison, and this is where it gets interesting: 5% on placebo, 9% at 2.4 mg, 11% at 7.2 mg.[1]

More drug, more tiredness. That pattern is hard to explain by anything other than the drug.

A dose-response relationship is one of the classic arguments for causation. If fatigue were simply a consequence of eating less or losing weight, you would expect it to track weight loss rather than milligrams — and while higher doses do produce more weight loss, the stepwise pattern across three arms is at least suggestive that the drug contributes directly.

What is probably going on

This section is inference. There is no trial that took people with fatigue on a GLP-1, tested an explanation, and reported a result. What there is: several well-established mechanisms that plausibly apply, each of which has its own evidence base elsewhere.

  1. You are eating substantially less. A large calorie deficit produces tiredness in anyone, by any method. This is the most likely single contributor and the least specific to these drugs.
  2. Dehydration. Nausea, vomiting and diarrhea all reduce fluid intake and increase losses, and dehydration causes fatigue well before it causes anything worse. It is also the mechanism behind the acute kidney injury the label warns about — see kidneys.
  3. Under-eating protein specifically. Appetite suppression tends to cut protein first, because protein-rich foods are the ones that feel heaviest. Our protein calculator works a target.
  4. Losing lean tissue. Roughly a quarter to a third of weight lost is lean mass, which is comparable to what lifestyle programs cost — the lean mass article covers it. Less muscle means the same task takes more of what you have.
  5. Low blood sugar, if you take something else for it. Fatigue is a hypoglycemia symptom, and the risk lives with insulin and sulfonylureas rather than the GLP-1 — the low blood sugar article sets that out.
Notice what that list is. Every item is well evidenced as a cause of fatigue in general, and none has been demonstrated as the cause of fatigue on these drugs specifically. That is a real distinction and most articles on this topic blur it. The list is a reasonable place to start looking, not a set of findings.

What is worth checking rather than assuming

Fatigue is the least specific symptom in medicine, and starting a new drug is exactly when a different cause gets attributed to it. The things worth ruling out are cheap to check and common in this population.

  • Thyroid function, which is a routine test and a routine cause.
  • Iron and B12, both of which fall when intake drops, and both of which cause exactly this.
  • Sleep apnea, which is common in this population and improves with weight loss — see sleep apnea.
  • Mood, because low energy and low mood are hard to tell apart from the inside.

None of that is a reason to assume the drug is innocent. It is a reason not to assume it is guilty, which is what happens when a new medicine gets blamed for everything that follows it.

When it is not ordinary tiredness

Fatigue that arrives with a racing heart, dizziness on standing, or an inability to keep fluids down is a dehydration picture rather than a tiredness one, and it is the pattern that precedes kidney injury. Fatigue with confusion, sweating or shakiness in someone taking insulin or a sulfonylurea should be treated as low blood sugar until proven otherwise. Both are same-day problems.

Frequently Asked Questions

References

  1. 1.Novo Nordisk Inc. WEGOVY (semaglutide) — US Prescribing Information, Section 6.1 Adverse Reactions: fatigue 11% vs 5% placebo (2.4 mg, N=2,116) and 5%/9%/11% across placebo, 2.4 mg and 7.2 mg (N=1,311) (revised 06/2026) DailyMed (FDA-approved labeling). 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b

GLP-1 Drugs and Low Blood Sugar: Who Is Actually at Risk

A GLP-1 alone is a poor cause of hypoglycemia, because it prompts insulin only when glucose is already high. The risk belongs to what it is taken alongside — and the label says one combination has never been evaluated.

6 min read

GLP-1 Drugs and Suicidal Thoughts: The Warning Came Off in 2026

The Suicidal Behavior and Ideation section was removed from the Wegovy, Zepbound and Saxenda labels in February 2026, after three large studies looked for a signal and none found one.

7 min read

GLP-1 Drugs and Your Kidneys: Protective Over Years, Risky Over Days

Semaglutide cut the risk of kidney failure or kidney death by 24% over a median 3.4 years. The label also warns of acute kidney injury in people dehydrated by vomiting or diarrhea. Both are true.

7 min read

Eating Too Little on a GLP-1: What the Deficiency Data Show

Across 480,825 adults, more than 60% were consuming below estimated requirements, vitamin D deficiency reached 13.6% at a year, and ferritin ran 26–30% below an active comparator.

7 min read

Food Noise: A Patient’s Word That Now Has a Questionnaire

Patients coined the term and the literature followed. It now has a validated five-item instrument — and a 2026 commentary arguing it may not describe anything distinct.

7 min read

GLP-1 Drugs After 65: Strength, Not Just Weight

Grip strength held up in general adult trials even as lean mass fell. In older adults with type 2 diabetes, prolonged use has been linked to the opposite — and no guidelines exist for this age group.

7 min read

Where to get semaglutide (Ozempic / Wegovy) online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.7

Try Ageless

Semaglutide at $119/month, 37% under the register median

9.4

Trimi Health

Knowing which pharmacy fills the vial — it names VialsRx

6.4

ShedRx

Oral orforglipron alongside the injectables